<?xml version="1.0" encoding="utf-8"?>
<Journal>
<Journal-Info>
<name>International Journal of Pharma and Bio Sciences</name>
<website>ijpbs.net</website>
<email>editorijpbs@rediffmail.com (or) editorofijpbs@yahoo.com (or) prasmol@rediffmail.com</email>
</Journal-Info>
<article>
<article-id pub-id-type='other'>10.22376/ijpbs.2019.10.1.p1-12</article-id>
<issue_number>Volume 2 Issue 2</issue_number>
<issue_period>2011 (April - June) </issue_period>
<title>A Review Article On "Role Of Fibroblast Growth Factor (FGF21) In Diabetes"</title>
<abstract>FGFs have diverse roles in regulating cell proliferation, migration and differentiation. Their actions are dependent on their ability to bind and activate a family of cell surface receptors with intrinsic protein tyrosine kinase activity. These receptors possess an extracellular cytoplasmic ligand-binding domain that has three immunoglobulin-like (Ig-like) regions, a hydrophobic transmembrane domain, and a discontinuous intracellular tyrosine kinase domain exhibiting a short intervening sequence. FGF-21 also improves the lipoprotein profiles by decreasing LDL-cholesterol and total cholesterol, and increasing HDL cholesterol. FGF-21 transgenic mice exhibit similar metabolic characteristics, namely reduced adiposity and resistance to diet-induced metabolic disturbances.</abstract>
<authors>Ashish Kakkar</authors>
<keywords>Fibroblast,diabetes,lipoprotein.</keywords>
<pages>469-474</pages>
</article>
</Journal>
